Identification
Personal identification
- Full name
- ANA TERESA MONTEIRO AMARAL
Citation names
- Amaral, Ana
Author identifiers
- Ciência ID
- FD1F-F6B7-E53E
- ORCID iD
- 0000-0001-7887-4814
- Google Scholar ID
- https://scholar.google.com/citations?user=mJF59dYAAAAJ&hl=pt-PT
Websites
- https://www.linkedin.com/in/ana-teresa-amaral-b089b62b/ (Professional)
- https://twitter.com/ATeresaAmaral (Social media)
Knowledge fields
- Medical and Health Sciences - Medical Biotechnology - Gene-based Diagnostics and Therapeutic Interventions
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Portuguese (Mother tongue) | |||||
English | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) |
Spanish; Castilian | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) |
Italian | Intermediate (B1) | Intermediate (B1) | Elementary (A2) | Intermediate (B1) | Beginner (A1) |
French | Elementary (A2) | Elementary (A2) | Elementary (A2) | Intermediate (B1) | Beginner (A1) |
Education
Degree | Classification | |
---|---|---|
2014 - 2015
Concluded
|
Clinical Trials (Master)
Universidad de Sevilla, Spain
|
8.3/10 |
2009 - 2014/09/18
Concluded
|
Biologia Molecular y Clínica del Cancer (Doctor of Philosophy)
Major in Biologia Molecular y Clínica del Cancer
Universidad de Salamanca, Spain
Instituto de Biología Molecular y Celular del Cáncer, Spain "The pathogenesis of Ewing Sarcoma: Implications of Mesenchymal Stem Cells and New Therapeutic Strategies" (THESIS/DISSERTATION)
|
Sobresaliente, Cum Laude |
2008/09 - 2010/12
Concluded
|
Biologia molecular y Clinica del Cancer (DEA)
Major in Molecular oncology
Universidad de Salamanca, Spain
"Estudio de la Célula Stem Mesenquimal en Sarcoma de Ewing" (THESIS/DISSERTATION)
|
|
2002 - 2008
Concluded
|
Ciências Farmacêuticas (Mestrado integrado)
Universidade de Coimbra Faculdade de Farmácia, Portugal
|
15 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2024/09/01 - Current | Auxiliary Researcher (Research) | Tumor Microenvironment and Targeted Therapies group-CNC-UC, Portugal |
ERA Fellowships - European Research Executive Agency, Portugal | ||
2021 - Current | Science and Technology Management | España Ministerio de Ciencia e Innovación, Spain |
2023/05/04 - 2024/08/31 | Auxiliary Researcher (Research) | Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra, Portugal |
2023/03/01 - 2023/04 | Science and Technology Management | Nordic Innovators P/S, Denmark |
2014/12/31 - 2022/12/31 | Auxiliary Researcher (Research) | Instituto de Biomedicina de Sevilla, Spain |
Instituto de Biomedicina de Sevilla, Spain | ||
2022/09/01 - 2022/12/01 | Visiting Researcher (Research) | Universidade de Coimbra, Portugal |
Tumor Microenvironment and Targeted Therapies group-CNC-UC, Portugal | ||
2018/09 - 2018/12 | Visiting Researcher (Research) | The Institute of Cancer Research, United Kingdom |
The Institute of Cancer Research, United Kingdom | ||
2009 - 2014 | Researcher (Research) | Instituto de Biología Molecular y Celular del Cáncer, Spain |
Instituto de Biología Molecular y Celular del Cáncer, Spain | ||
2008 - 2009 | Research Trainee (Research) | Instituto de Biología Molecular y Celular del Cáncer, Spain |
Instituto de Biología Molecular y Celular del Cáncer, Spain |
Projects
Grant
Designation | Funders | |
---|---|---|
2024/01/09 - 2026/08/31 | ERA Fellowships (HORIZON-WIDERA-2022-TALENTS-04)
Post-doc
|
|
2022/01/01 - 2023 | Tailored adoptive cellular immunotherapy for Ewing Sarcoma
Post-doc
Instituto de Biomedicina de Sevilla, Spain
Fundación Josep Carreras contra la Leucemia, Spain |
Obra Social La Caixa
Ongoing
|
Contract
Designation | Funders | |
---|---|---|
2023/05/01 - 2024/08/31 | CInTech: Technological Hub for Innovation, Translation and Industrialization of Complex Injectable Drugs
Post-doc Fellow
Universidade de Coimbra, Portugal
Bluepharma, Portugal |
Ongoing
|
2021 - 2023 | Integrative molecular-testing platform for precision diagnostics and personalized care of sarcoma patients
Post-doc
Instituto de Biomedicina de Sevilla, Spain
Hospital Universitario Virgen del Rocío, Spain |
Fundacion Maripaz Jimenez Casado
Ongoing
|
2020 - 2023 | Study of the prognostic and functional role of mesenchymal stem cell markers Endoglin and ALCAM in the disease progression
of Clear cell sarcomas (CCS) and Desmoplastic small Round cell tumors (DSRCT)
P18-RT-735
Principal investigator
Instituto de Biomedicina de Sevilla, Spain
|
Junta de Andalucía
Concluded
|
2020 - 2023 | New insights into the Desmoplastic small round cell tumour: comprehensive molecular characterization to identify therapeutic
targets and new biomarkers
400300200313
Principal investigator
Instituto de Biomedicina de Sevilla, Spain
|
Grupo Espanol Investigacion Sarcomas
Ongoing
|
2019 - 2023 | Translational assessment of predictive factors of response of Ewing sarcoma to genotoxic therapy
S1900239
Principal investigator
Instituto de Biomedicina de Sevilla, Spain
Hospital Universitario Virgen del Rocío, Spain University College London, United Kingdom University of Michigan, United States |
Sarcoma Foundation of America |
2019 - 2022/12 | CIBERONC-Centro de Investigacio Biomedica en RED: Low prevalence tumours program
Post-doc
Centro de Investigación Biomédica en Red de Cáncer, Spain
|
Ongoing
|
2021 - 2022 | Intratumoral heterogeneity in t-sarcomas: A silver lining for precision therapeutics
PI20-0003
Post-doc
Instituto de Biomedicina de Sevilla, Spain
|
Instituto de Salud Carlos III
Ongoing
|
2020 - 2022 | Evaluación de STAT6 como biomarcador de diagnóstico de precisión y diana terapéutica en Tumor Fibroso Solitario
PI-0061-2020
Post-doc
Instituto de Biomedicina de Sevilla, Spain
Hospital Universitario Virgen del Rocío, Spain |
Junta de Andalucía
Ongoing
|
2018 - 2021 | Evaluation of the clinical potential of the vesicular crosstalk in response to drugs in the context of Ewing sarcoma. PI-0040-2017
PI-0040-2017
Principal investigator
Instituto de Biomedicina de Sevilla, Spain
|
Junta de Andalucía |
2018 - 2020 | Nuevas dianas terapéuticas en el sarcoma de Ewing a través del estudio del proceso metastásico
PI1700464
Post-doc
Instituto de Biomedicina de Sevilla, Spain
|
Instituto de Salud Carlos III
Concluded
|
2018 - 2019 | PROYECTO 3D-ID CULTIVOS 3D PERSONALIZADOS PARA SELECCIÓN DE TRATAMIENTO PARA PACIENTES DE CÁNCER EN MEDICINA DE PRECISIÓN
Post-doc
Instituto de Biomedicina de Sevilla, Spain
STEMTEK THERAPEUTICS SL, Spain FUNDACIÓN ONKOLOGIKOA FUNDAZIOA, Spain Institut d'Investigació Biomèdica de Bellvitge, Spain |
Cancelled
|
2017 - 2018 | PROspective VAlidation of Biomarkers in Ewing Sarcoma for personalized translational medicine
Post-doc
Hospital Universitario Virgen del Rocío, Spain
IRCCS Istituto Ortopedico Rizzoli, Italy St James's University Hospital, United Kingdom Institut Curie, France Klinikum rechts der Isar der Technischen Universität München, Germany |
European Commission
Concluded
|
2014 - 2017 | Nuevas dianas terapéuticas en el sarcoma de Ewing: estudio del micromedioambiente
PI14/01466
Post-doc
Instituto de Biomedicina de Sevilla, Spain
|
Instituto de Salud Carlos III
Concluded
|
2014 - 2016 | ENDOWING RELEVANCIA DE LA ENDOGLINA EN LA PATOLOGÍA DEL SARCOMA DE EWING: DESARROLLO DE TRATAMIENTOS PERSONALIZADOS INNOVADORES
Post-doc
Instituto de Biomedicina de Sevilla, Spain
Oncomatryx, Spain |
Concluded
|
Outputs
Publications
Conference poster |
|
Journal article |
|
Preprint |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2023/11/14 | Unraveling gene fusion dependent transcription factors in Desmoplastic Small Round Cell Tumor | ASEICA 40th Anniversary Congress,
ASEICA (Coruña, Spain)
|
2021/12/14 | Desmoplastic Small Round Cell Tumor on the spotlight- Senior Author-Oral Presentation | Desmoplastic Small Round Cell Tumor on the spotlight
CIBERONC (barcelona, Spain)
|
2021/12/13 | Dissecting the role of Rloops in Ewing sarcoma chemosensitivity- Contributing Author- Face to Face poster | IV Young Researchers Meeting CIBERONC-BBN
CIBERONC (barcelona, Spain)
|
2021 | Circulating Biomarkers in Sarcomas with Translocations https://www.youtube.com/watch?v=ARO08iHZGBc&t=940s | Precision diagnostics and follow-up of sarcoma patients
Asociación Sarcomas de Galicia (Galician Sarcoma Association) ASARGA (Spain)
|
2018/09/06 | ¿Por qué elegimos el melanoma uveal como proyecto de investigación para CIBERONC? https://www.gethi.org/contenidos/apartados/detalleApartado.aspx?idTipoApartado=i2%2F7o8SaukHJdF9r3vmW1Q%3D%3D&idCategoria=vcmxUUdhbPZVNx3%2FeyzeOQ%3D%3D&idApartado=d5XrZo1yr%2BR63bnHoZKy5A%3D%3D | I Jornada GETHI CIBERONC
GETHI (Sevilla, Spain)
|
2017 | Rationale for the combination of Lurbinectedin/Trabectedin with Olaparib (Update) | Incorporating EURO-EWING 99 and EWING 2008
EURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma (london, United Kingdom)
|
2016/09/09 | Dual targeting of Ewing sarcoma and the tumor microenvironment | PROVABES/EORTC/DKTK/EEC_WP3&4 Meeting
Transcan-2 translational cancer research program (Essen, Germany)
|
2016 | The potential application of exosomes in the clinical setting of Ewing Sarcoma |
SEAP-IP (Spanish Society of Pathology) (Madrid, Spain)
|
2014 | Transcriptional downregulation of EWSR1-FLI1, induction of DNA damage and anti-IGF1R therapies in the treatment of Ewing Sarcoma http://www.ibis-sevilla.es/media/8087/Memoria_Anual_IBiS_2014.pdf | XI Foro de Investigadores. Institute of Biomedicine of Seville
Insituto de Biomedicina de Sevilla (Sevilla, Spain)
|
2010 | Preclinical Evaluation of OSI-906 and Trabectedin effects on Ewing Sarcoma cells | 1st Annual Eurosarc Meeting
EUROSARC (Treviso)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2023/08 - Current | Deciphering the role of membrane Nucleolin in newly engineered in vitro models of Prostate Cancer
Co-supervisor
|
Mestrado em Biotecnologia Farmacêutica (Master)
Tumor Microenvironment and Targeted Therapies group-CNC-UC, Portugal
|
2021 - 2023 | Desmoplastic Small Round Cell Tumor on the spotlight: Comprehensive molecular and functional characterization of new biomarkers
and actionable targets
Co-supervisor
|
Instituto de Biomedicina de Sevilla, Spain
|
2021/09 - 2022/06 | Genomic and functional studies in clear cell sarcoma models
Co-supervisor
|
Biomedicina (Degree)
Universidad de Sevilla, Spain
|
2020 - 2021 | Uveal Melanoma: New Therapeutic Opportunities
Co-supervisor
|
Medicina y Cirugia (Degree)
Universidad de Sevilla-Facultad de Medicina, Spain
|
2017 - 2021 | Endoglin in Ewing Sarcoma: from the biological relevance to a clinical strategy
Co-supervisor
|
Instituto de Biomedicina de Sevilla, Spain
|
2019 - 2020 | New contributions on the Desmoplastic Small Round Cell Tumor: establishment of pre-clinical models for the identification
of new targets and biomarkers
Co-supervisor
|
Master en Biomedicina (Master)
Instituto de Biomedicina de Sevilla, Spain
|
2018 - 2019 | Endoglin/ALCAM as potential therapeutic targets in Clear Cell Sarcoma and Desmoplastic Small Round Cell Tumor
Co-supervisor
|
Universidad de Sevilla-Biomedicina (Degree) |
2017 - 2018 | Generation of knockout models for ALCAM of Uveal Melanoma and Ewing sarcoma
Co-supervisor
|
Biomedicina (Degree)
Universidad de LLeida Biomedicina , Spain
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2024/03/08 - 2024/03/08 | Outreach activity at the Almas de Freire Primary School.
Workshop:
" O que são células?"
"Como funcionam as vacinas?"
"O que é a luz?"
(2024/03/08 - 2024/03/08)
Workshop (Co-organisor)
|
Universidade de Coimbra, Portugal |
2023/02/11 - 2023/02/11 | Outreach Activity at the Almas de Freire Priimary School:
Workshop:
"O que fazem os investigadores?" (2023/02/11 - 2023/02/11)
Workshop (Co-organisor)
|
Escola Almas de Freire, Santa-Clara, Portugal Universidade de Coimbra, Portugal |
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2022/02/11 - Current | CaixaResearch: Colaboración Dia Mundial del Cáncer infantil
Workshop
|
Dia Mundial del Cáncer infantil
Obra Social La Caixa, Spain
|
2020/02/11 - Current | Women In Science, February 11. “Meet Our Researchers”
Science Dissemination Activities with children and high school students
https://twitter.com/LabHuvr/status/1368943413706584073/photo/1
Seminar
|
Women In Science, February 11. “Meet Our Researchers” |
2019 - Current | Science Dissemination Activities with children and high school students
Science Fair-Seville
https://twitter.com/LabHuvr/status/1129309616288993280/photo/1
Workshop
|
Science Fair-Seville |
2015/02/09 - Current | TUMOR MICROENVIRONMENT IN EWING SARCOMA. SEARCH FOR NEW DIAGNOSTIC TOOLS, AND THERAPEUTIC APPROACHES
Seminar
|
Seminario Program de Onco-Hematología y Genética
Hospital Universitario Virgen del Rocío, Spain
|
2024/03/05 - 2024/03/05 | Outreach activity at the UC Exploratório - Ciência Viva Coimbra for pre-schoolers " O que é o DNA?"
Workshop
|
" O que é o DNA?"
UC Exploratório - Ciência Viva Coimbra , Portugal
|
2022/06/20 - 2022/06/23 | Exploring the role of Endoglin in the aggressiveness of Ewing and Clear Cell Sarcoma
Poster Presentation
First author
Congress
|
EACR 2022 Congress - Innovative Cancer Science
European Association For Cancer Research, United Kingdom
|
2022/06/20 - 2022/06/23 | Optical Genome Mapping: Unravelling the genomic landscape of Solitary Fibrous Tumor
Poster Presentation
Collaborator author
Congress
|
EACR 2022 Congress - Innovative Cancer Science: Translating Biology to Medicine
European Association For Cancer Research, United Kingdom
|
2022/06/20 - 2022/06/23 | Desmoplastic Small Round Cell Tumor: modelling the disease
Poster Presentation
Senior author
Congress
|
EACR 2022 Congress - Innovative Cancer Science: Translating Biology to Medicine
European Association For Cancer Research, United Kingdom
|
2021/12/10 - 2021/12/11 | 100 years Ewing Sarcoma: Learning from the past, Challenges for the future
Congress
|
100 years Ewing Sarcoma: Learning from the past, Challenges for the future
Sarcoma Patients EuroNet EV, Germany
|
2018 - 2018 | Unravelling endoglin as a potential therapeutic target for the treatment of uveal melanoma
First author, poster presentation
https://www.sciencedirect.com/science/article/pii/S2059702920320421
Congress
|
EACR- 25
European Association For Cancer Research, United Kingdom
|
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2024/10/20 | UNRAVELLING THE ROLE OF EFEMP1 IN THE METASTATIC CASCADE OF OSTEOSARCOMA
(Thesis) Main arguer
|
Beatriz Isabel Gomes Salgado (Master)
Faculdade de Medicina da Universidade de Coimbra, Portugal
|
2024/07/10 | Unveiling the Future of Immunotherapy through mRNA-LNPs Therapies
(Thesis) Main arguer
|
Ana Carolina dos Santos Andrade (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
|
2023/09/26 | Cancer Immunotherapy: Current Landscape and Future Directions
(Thesis) Main arguer
|
Joana Sousa Pereira Nogueira Brito (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
|
Association member
Society Organization name | Role | |
---|---|---|
2024 - Current | Sociedade Portuguesa de Imunologia - SIP | Member |
2019 - Current | Member of the GETHI network. (Spanish group of Orphan and infrequent tumors) | Membro |
2018 - Current | CIBERONC network (Cancer Network Biomedical Research Center), Low Prevalence Tumours Program | Membro Adscrito a Grupo de Trabalho |
2017 - Current | Spanish group for sarcoma research (Grupo GEIS) | Membro |
2008 - Current | Ordem dos Farmacêuticos | Mem |
2016 - 2020 | The European Association for Cancer Research | EACR ambassador (From 2016-2020) |
2016 - 2020 | Associação Portuguesa de Investigação em Cancro ASPIC | Membro |
Committee member
Activity description Role |
Institution / Organization | |
---|---|---|
2019 - Current | Member of the Immunology central working
Member
|
Centro de Investigación Biomédica en Red de Cáncer, Spain |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2024 - 2024 | Mestrado Biotecnologia Farmaceutica-Módulo VI: Biofármacos na Prática Clínica | Mestrado em Biotecnologia Farmacêutica (Mestrado) | Universidade de Coimbra Faculdade de Farmácia, Portugal |
2023 - 2023 | Mestrado Biotecnologia Farmaceutica-Módulo VI: Biofármacos na Prática Clínica | Mestrado Biotecnologia Farmaceutica-Módulo VI (Curso de mestrado (conclusão do curso de especialização)) | Universidade de Coimbra Faculdade de Farmácia, Portugal |
Evaluation committee
Activity description Role |
Institution / Organization | Funding entity | |
---|---|---|---|
2021 - Current | Expert, external reviewer for the Spanish National Research Agency in 22 projects/grants |
Interview (newspaper / magazine)
Activity description | Newspaper / Forum | |
---|---|---|
2019 | Awarded EACR travel grant for an international short-stay. https://magazine.eacr.org/it-was-a-pleasure-ana-amaral-eacr-travel-fellow/ | https://magazine.eacr.org/it-was-a-pleasure-ana-amaral-eacr-travel-fellow/ |
Journal scientific committee
Journal title (ISSN) | Publisher | |
---|---|---|
2020 - Current | Frontiers in Immunology and Frontiers in Oncology | Frontiers |
2022/12 - 2023/05 | Frontiers in Immunology (1664-3224) |
Mentoring / Tutoring
Topic | Student name | |
---|---|---|
2020 - 2023 | Desmoplastic Small Round Cell Tumor on the spotlight: Comprehensive molecular and functional characterization of new biomarkers and actionable targets | Laura Lobo Selma |
Distinctions
Award
2023 | HORIZON-WIDERA-2022-TALENTS-04
European Commission, Belgium
|
2022 | CIBERONC Travel Grant 2022-international fellowship
Centro de Investigación Biomédica en Red de Cáncer, Spain
|
2019 | "Juan de la Cierva" incorporation grant for a Post-Doctoral position
España Ministerio de Ciencia e Innovación, Spain
|
2018 | CIBERONC Travel grant for an international fellowship
Centro de Investigación Biomédica en Red de Cáncer, Spain
|
2018 | EACR travel grant for an international short-stay
European Association For Cancer Research, United Kingdom
|
2010 | PhD grant funded by the Fundação para a Ciência e Tecnologia, Portugal
Fundação para a Ciência e a Tecnologia, Portugal
|